Department of Health publishes NHS Operating Framework for 2012/13

The Department of Health has today published the NHS Operating Framework for 2012/13.  The Framework sets out national priorities as well as the system levers that will be used to ensure that NHS organisations provide high quality services. 

The Framework sets out how proxy measures will be used to measure achievement against the NHS Outcomes Framework, under each of the five domains.  Those most relevant to cancer are:

Domain 1: Preventing people from dying prematurely

  • Early treatment secures better outcomes where patients have cancer symptoms.  We expect all four of the 31 day operational standards and all three of the 62 day operational standards to continue to be met or exceeded

Domain 2: Enhancing quality of life for people with long term conditions

  • Patients with cancer need to know that services are responsive when their GP recommends urgent specialist attention and we expect this and the standard for two week waits from GP referral for breast symptoms to be met

National quality measures include:

Domain 1: Preventing people from dying prematurely

  • Cancer 31 day, 62 day waits

Domain 4: Ensuring people have a positive experience of care

  • Cancer 2 week waits

The full document is available here.

Page published: Thu 24 November 2011

It is supported by 12 companies:

  • Amgen
  • Astra Zeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • GE Healthcare
  • GSK
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Sanofi Aventis